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Abstract
Scedosporium apiospermum is part of the Pseudallescheria-Scedosporium complex. Peptidorhamnomannans (PRMs) are cell
wall glycopeptides present in some fungi, and their structures have been characterized in S. apiospermum, S. prolificans and
Sporothrix schenckii. Prior work shows that PRMs can interact with host cells and that the glycopeptides are antigenic. In the
present study, three monoclonal antibodies (mAbs, IgG1) to S. apiospermum derived PRM were generated and their effects
on S. apiospermum were examined in vitro and in vivo. The mAbs recognized a carbohydrate epitope on PRM. In culture,
addition of the PRM mAbs increased S. apiospermum conidia germination and reduced conidial phagocytosis by J774.16
macrophages. In a murine infection model, mice treated with antibodies to PRM died prior to control animals. Thus, PRM is
involved in morphogenesis and the binding of this glycopeptide by mAbs enhanced the virulence of the fungus. Further
insights into the effects of these glycopeptides on the pathobiology of S. apiospermum may lead to new avenues for
preventing and treating scedosporiosis.
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Introduction
The filamentous and saprophytic fungus Scedosporium apiosper-
mum is an emerging clinically important pathogen that causes
localized as well as disseminated infections in both immunocom-
petent and immunocompromised hosts [1–2]. S. apiospermum is an
important cause of mycetoma, acquired by traumatic inoculation.
Additionally, the fungus can be acquired through inhalation
followed by deposition into the lungs or paranasal sinuses, with
similar symptoms to those observed in diseases secondary to
Aspergillus fumigatus. Dissemination most frequently occurs in
immunocompromised individuals and is associated with high
mortality rates (.75%) [3]. A large number of cases of
pseudallescheriosis/scedosporiosis have been reported in children
with cystic fibrosis [4], patients with leukemia [5] and organ
transplant recipients [6–7]. Despite the rising frequency of S.
apiospermum infections, its pathogenesis and the mechanism by
which S. apiospermum evades host pulmonary defenses and reaches
other organs are poorly understood. Recently, the innate immune
response has been shown to be critical for host defense against
Pseudallescheria -Scedosporium complex fungi [8]. Importantly, these
species are largely resistant to traditional antifungals such as
amphotericin B; however, newer triazoles, such as voriconazole,
can be therapeutic [3].
Microbial adherence is a prerequisite for colonization and an
essential step in the establishment of infection [9]. The
composition of the fungal cell surface is of primary importance
in the cell response to environmental stimuli and, in this context,
glycopeptides are important determinants for many biological
activities. Elucidation of the primary structure of surface microbial
glycopeptides, especially those that function as virulence determi-
nants, is of great relevance to understanding the pathobiology
of a microbe. The mechanisms of adherence and invasion
have been studied in several fungal species, including Candida
albicans, Histoplasma capsulatum, A. fumigatus, Paracoccidioides brasilien-
sis, Sporothrix schenckii, Fonsecaea pedrosoi, Trichophyton mentagrophytes
and Trichophyton rubrum (reviewed in [9]). However, little is known
regarding the adherence and invasion mechanisms for the S.
apiospermum/S. apiospermum species complex, although their conidia
can attached to and are internalized by HEp 2 cells through a
lectin-mediated process involving a peptidorhamnomannan of the
fungal cell wall [10].
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from mycelial forms of S. apiospermum has been characterized
chemically and immunologically [11]. S. apiospermum PRM consists
of a peptide chain substituted with both O-linked and N-linked
glycans. It reacts strongly with antiserum against S. apiospermum
mycelium, and this interaction is weakly inhibited by the PRM
from S. schenckii or by peptidogalactomannan from A. fumigatus,
suggesting that S. apiospermum expresses antigens that are related to
S. schenckii peptidopolysaccharide [12] and the major Aspergillus
glycopeptide [11,13].
To gain a better understanding of PRM function in S.
apiospermum, we generated murine monoclonal antibodies (mAbs)
against PRM. Interestingly, the mAbs promoted conidial germi-
nation. Infection of macrophage monolayers with opsonized S.
apiospermum conidia resulted in a significant increase in the killing
of macrophages and a decrease in phagocytosis in comparison
with non-opsonized conidia. Mice that received the mAbs prior to
S. apiospermum infection died more rapidly than control animals.
These results suggest that mAbs to PRM change the physiology of
S. apiospermum cells by altering the kinetics of germination and
modifying fungal-host interactions, which dramatically impacts the
outcome of disease.
Materials and Methods
Microorganism and growth conditions
S. apiospermum strain HLPB (formerly Pseudallescheria boydii),
isolated from a patient with eumycotic mycetoma, was kindly
supplied by Dr. Bodo Wanke from Instituto de Pesquisa Evandro
Chagas, Fundac ¸a ˜o Oswaldo Cruz, Rio de Janeiro, Brazil. The
isolate was confirmed as S. apiospermum by molecular methods
developed by Dr. Kathrin Tintelnot (Robert Koch-Institut, Berlin,
Germany). The sequencing of the ITS regions revealed that this
strain belongs to clade 4 (S. apiospermum sensu stricto) according to
the taxonomy proposed by Gilgado et al. [14]. Cells were
maintained on potato dextrose (PD) agar slants. Fresh cultures
were inoculated in PD liquid culture medium and incubated for 7
days at 25uC with shaking. Conidia were grown on Petri dishes
containing PD agar medium at 30uC. After 7 days in culture,
conidia were obtained after washing the plate surface with
phosphate-buffered saline (PBS- 10 mM NaH2PO4,1 0 m M
Na2HPO4 pH 7.0 and 150 mM NaCl) and filtering through
gauze to remove hyphal fragments and debris. Conidia were
washed three times and counted with a hematocytometer.
S. apiospermum clade 5 (S. apiospermum sensu stricto) [14] and
Scedosporium prolificans strains were kindly supplied by Dr. J. Guarro
from Unitat de Microbiologia, Facultat de Medicina e Institut
d’Estudis Avanc ¸ats, Re ´us, Spain. Cells were maintained on
Sabouraud (SAB - 2% glucose, 1% peptone, 0.5% yeast extract)
agar slants. Fresh cultures were inoculated in SAB liquid culture
medium and incubated for 7 days at 25uC with orbital shaking.
Conidia were grown on Petri dishes containing SAB agar medium
at 30uC. After 7 days in culture, conidia were obtained as
described for S. apiospermum. Candida albicans SC5314 (ATCC,
MYA-2876), Candida parapsilosis GA1 [15], and Histoplasma
capsulatum G217B (ATCC, 26032) were maintained at 280uCi n
35% glycerol. Yeast phases of the Candida species were produced in
YPD (1% yeast extract, 2% bactopeptone, 2% glucose) at 30uC
and H. capsulatum yeasts were grown in YPD at 37uC.
Reagents and cell lines
Agoatanti-mouse(GAM)IgG(SouthernBiotechnologyAssociates
Inc., Birmingham, AL) was used as an isotype-matched control in all
the experiments. The fluorescence probe 5-(and 6)-carboxytetra-
methylrhodamine succinimidyl (NHSRho) was obtained from
Molecular Probes (Eugene, OR). Triton X-100, fluorescein isothio-
cyanate (FITC)-dextran (molecular weight, 70,000), MTT [3-(4,5-
dimethyl-thiazol-2-yl) 2,5-diphenyl tetrazolium bromide], and para-
formaldehyde were from Sigma-Aldrich (St. Louis, MO). Tetra-
methyl Rhodamine Isothiocyanate (TRITC) was obtained from
Southern Biotechnology Associates Inc. SuperBlock buffer in
phosphate-buffered saline (PBS) and EZ-Link sulfo-N-hydroxysulfo-
succinimide – biotin kit were from Pierce (Rockford, IL). The
macrophage-like cell line J774.16 (derived from a reticulum cell
sarcoma) was obtained from the ATCC. The J774.16 cells were
grown with DMEM (Life Technologies, Carlsbad, CA) containing
10% fetal calf serum (Gemini Bio-Products, Woodland, CA), 10%
NCTC-109 (Life Technologies), 1% nonessential amino acids
(Mediatech, Manassas, VA) and 1% Penicillin-Streptomycin (In-
vitrogen, Carlsbad, CA) at 37uCi n5 %C O 2. The cell counts and
viability for all the experiments were determined by trypan blue vital
dye exclusion using a hemacytometer. For conidia, this method
demonstrated an initial viability of .95%, as confirmed by plating.
PRM was produced as described [11].
Generation of mAbs against S. apiospermum
peptidorhamnomannans
All murine studies were performed in accordance with the rules
and regulations of animal welfare at Federal University of Rio de
Janeiro (UFRJ, RJ, Brazil) and the Albert Einstein College of
Medicine (Bronx, NY, USA). Four 6 week old female BALB/c
mice (from UFRGS,RS, Brazil) were immunized intraperitoneally
with 20 mg of PRM emulsified in complete Freund’s adjuvant for
the first injection and 20 mg of antigen in incomplete Freund’s
adjuvant for the subsequent three injections. Injections were
spaced at a two-week intervals and the immune response against
PRM was monitored by indirect ELISA. Sera were obtained 1
week after the last immunization and analyzed for the presence of
antibodies to PRM by ELISA, using 500ng of the antigen per well.
The animal whose serum showed the highest level of immuniza-
tion (OD value 6.5 times higher than the serum of a non-
immunized animal) was boosted intraperitoneally with 50 mgo f
the antigen without adjuvant 3 days prior to spleen removal and
fusion of splenocytes with murine myeloma tumor cells (SP2/0)
using polyethylene glycol (PEG). Hybridomas that survived
selection in hypoxanthine-aminopterin-thymidine (HAT) medium
Author Summary
The incidence of fungal infections has increased dramat-
ically over the last 50 years, largely because of the
increasing size of the population at risk, which especially
includes immunocompromised hosts. Scedosporium apios-
permum is a filamentous fungus that causes a variety of
infections, ranging from localized disease to life-threaten-
ing disseminated infections. Glycoproteins are molecules
present in the fungal surface and are comprised of
carbohydrate and protein components. They are involved
in different important functions in the fungal cell.
Monoclonal antibodies can be used as therapeutic agents
for infectious disease, but some factors involved in their
efficacy are often not well understood. We found that
monoclonal antibodies to glycoproteins present in fungal
surface can be nonprotective and can even enhance the
disease. The administration of these antibodies can affect
functions of the fungal cell and the immune cells, resulting
in a survival advantage for the fungus during interactions
with the host.
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the antigen per well. Positive hybridomas were cloned by limiting
dilution and cryopreserved. The isotype of the selected mAbs was
determined with an isotyping kit (Sigma-Aldrich) according to the
manufacturer’s instructions. The murine mAbs C7, C11 and F10
of immunoglobulin G1 (IgG1) isotype were selected and used in all
assays. Clones were injected into the peritoneal cavity of BALB/c
mice previously treated with Pristane to generate ascites and the
antibodies to PRM were subsequently purified by protein G
affinity chromatography. The purified mAbs were screened to
ensure the absence of endotoxin with a Limulus amebocyte assay kit
(BioWhittaker Inc., Walkersville, MD).
Indirect ELISA
PRM was added (25–50 ng of protein in 50 mL of PBS [0.01M;
pH 7.2]) per well or 1610
6 swollen conidia (S. apiospermum strain
HLPB (clade 4), S. apiospermum strain clade 5 and S. prolificans)o r
yeasts (C. albicans, C. parapsilosis and H. capsulatum)i n5 0ml PBS per
well, followed by incubation for 1h at 37uC and then overnight at
4uC. Plates were washed three times with washing buffer (10 mM
Tris-buffered saline [TBS], 0.1% Tween 20 [pH 7.3]) and blocked
with 1% BSA in PBS (blocking buffer). Serial two-fold dilutions of
a 100 mg/mL solution of the different mAbs in blocking buffer
were added in duplicate to the wells and incubated at 37uC for
1 h. After three washes, the plates were incubated at 37uC for 1 h
with GAM IgG alkaline phosphatase conjugate (Southern Biotech,
Birmingham, AL) diluted 1:1,000 in blocking buffer at a final
volume of 100 mL per well. Plates were washed three times, and
then the enzymatic reaction was developed with the addition of
pNPP in substrate buffer at 37uC for 30 min. Absorbances were
measured on a microplate reader (Bio-Tek mQuant) at 405 nm.
Fluorescence microscopy
Immunofluorescence analysis was performed by co-incubating the
mAbs with S. apiospermum conidia. In order to assess mAb binding,
conidia were incubated in SuperBlock for 1 h at 37uC, washed three
times with PBS and incubated with either a mAb to PRM or an
isotype-matched control in 100mg/mLinSuperBlockfor1 hat37uC.
The cells were washed and incubated in 100 mlo fG A MI g G
conjugated with TRITC at a 1:100 dilution in SuperBlock for 1 h at
37uC. After three washes, cells were suspended in 50 mLo fa
mounting solution containing 0.01 M of N-propylgallate diluted in
PBS:glycerol (1:1, vol/vol). Ten microliters of the suspension was
applied to a microscope slide and examined with an Olympus AX70
fluorescence microscope (Olympus America Inc., Center Valley, PA)
using a 620-nm filter and a magnification of 640.
Competition ELISA
MAbs were biotinylated with a biotin commercial kit, according
to the manufacturer’s instructions (Pierce, Rockford, IL, USA).
ELISA plates were generated as described above, except the
concentration of PRM was 25ng/well. After blocking, a constant
concentration of the biotinylated mAb was incubated with
decreasing concentrations of a different non-biotinylated mAb in
blocking buffer for 1 h at 37uC. After washing, avidin conjugated
with alkaline phosphatase (Sigma-Aldrich) was added, and the
preparation was incubated for 1 h at 37uC. Absorbance at 405 nm
was recorded after the reaction was developed with pNPP.
Epitope characterization of mAbs by endoglycosidase
treatment
To remove N-linked glycans, 10 mg of PRM was treated with
100mU of PNGase F (P0704, New England Biolabs) at 37uC for
20 h. ELISA plates were made with 25 ng/well of the treated
PRM, the mAbs were applied, and the reaction developed as
described above.
Epitope characterization of mAbs by protease digestion
ELISA plates were made with 25ng/well of purified PRM and
the wells were incubated with Proteinase K (2.5 mg/mL; Sigma-
Aldrich) in 1% SDS solution for 1 h at 4uC [16]. After washing, the
mAbs were applied and the reaction developed as described above.
Phagocytosis assays
Phagocytosis assays were performed as described previously
[17]. Briefly, macrophage-like J774.16 cells were plated at a
concentration of 5610
5 cells per well in 24-well cell culture
polystyrene plates and grown overnight at 37uC in the presence of
5% CO2. S. apiospermum conidia were collected after 7 days of
growth, washed three times with PBS and 1610
6 conidia were
incubated with 100 mg/mL of a mAb to PRM, IgG isotype
control, or PBS for 1 h at 37uC. After washing, the fungal cells
were added to the macrophages at a ratio of 5:1 (conidia:ma-
crophage), and the plates were incubated for 1 h at 37uC in the
presence of 5% CO2. Samples were prepared in triplicate. Wells
were washed with PBS and fixed with a 40% methanol solution.
The numbers of macrophages and conidia were recorded for each
field, and at least 200 macrophages were counted. The
phagocytosis index was defined as the ratio of the number of
intracellular conidia relative to the number of macrophages
counted. A second phagocytosis experiment was performed with
J774.16 cells that were incubated with native PRM (100 mg/mL)
1 h before the interaction with S. apiospermum conidia.
To determine the mechanism of conidial engagement with
macrophages, additional phagocytosis experiments were performed
using fluorescence activated cell sorting (FACS). J774.16 cells were
incubated with anti-mouse CD11a, anti-mouse CD11b, anti-mouse
CD11c, anti-mouse CD14 or anti-mouse CD18 (Southern Biotech-
nology Associates Inc.) antibodies prior to interaction with S.
apiospermum conidia. The conidia were incubated in a solution of
0.5 mg/mL of FITC in PBS at 37uC for 30 min The conidia were
then washed three times with PBS and incubated with treated and
control macrophages for 60 min. Samples were washed three times
with PBS to remove extracellular conidia. For FACS measurements,
cells were suspended in 1 mL PBS and analyzed on a FACS-
Calibur
TM, equipped with a 5 W argon laser (Coherent) tuned to
488 nm, output power 250 mW (Becton Dickinson, San Jose, CA).
At least 10,000 events were enumerated for each condition [18].
Macrophage effector functions
The growth of S. apiospermum conidia in the presence of mAbs
was evaluated by incubating the fungus with mAbs to PRM,
isotype-matched control mAb, or PBS prior to co-culture with
macrophages. Washed conidia were added to wells containing
J774.16 cells at a ratio of 5:1 and incubated for 2 h. The cultures
were washed with cold PBS, and the macrophages were lysed by
adding sterile water. Aliquots were plated into potato dextrose
agar plates and incubated at 30uC. The percentage of growth was
determined by comparing the number of CFU for S. apiospermum
conidia pretreated with mAbs to the number of CFU for untreated
conidia.
Assay for phagolysosome formation
To further explore whether the mAbs affected the intracellular
fate of the fungus in macrophages, fusion of phagosomes and
lysosomes was evaluated as described [19]. Monolayers of J774.16
MAbs to PRM Modify Scedosporiosis
www.plosntds.org 3 October 2010 | Volume 4 | Issue 10 | e853Figure 1. MAb-labeled PRM on the cell surface of S. apiospermum. Immunofluorescence and bright-field microscopy showing labeling of
S. apiospermum by mAbs to PRM. Representative images of binding with mAbs F10 (A and B), C7 (C and D) and C11 (E and F). Bars: 10mm.
Representative curves for mAb binding to PRM of purified PRM (G) and of S. apiospermum conidia (H) as determined by indirect ELISA. The ELISA
assays were done in triplicate, three times.
doi:10.1371/journal.pntd.0000853.g001
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0.5 mg/mL FITC-dextran for 4 h at 37uC in the presence of
5% CO2. Cells were washed three times with PBS and incubated
overnight in medium alone. S. apiospermum conidia were collected,
washed, and incubated with 40 mg/mL NHSRho at 4uC for 1 h.
Conidia were washed and incubated with 100 mg/mL of mAb to
PRM, control mAb or PBS. Conidia were washed, suspended in
DMEM, and added to the culture of J774.16 cells at a ratio of 5:1.
The plates were then incubated for 1 h at 37uC in the presence of
5% CO2. The cells were fixed in 3.75% paraformaldehyde for
20 min at room temperature. Cells were observed by phase-
contrast and fluorescence microscopy at a magnification of 6400.
In J774.16 macrophages, the number of rhodamine-labeled S.
apiospermum conidia with co-localization of FITC-dextran and the
total number of intracellular labeled conidia for each condition
were counted to determine the percentage of phagosomes fused
Figure 2. MAbs to PRM compete for the same epitope in the carbohydrate portion of PRM molecule. Competition ELISA showing the
competition between mAbs F10, C7 and C11 (A). Absorbance values from ELISA with endoglycosidase-treated antigens and absorbance values from
ELISA with protease-treated antigens incubated with mAb F10 (B). The ELISA assays were done in quintuplicate, three times.
doi:10.1371/journal.pntd.0000853.g002
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labeled conidia co-localized with a green fluorescent dextran ring.
To evaluate the capacity of S. apiospermum conidia to germinate
and survive in acidic media, cells were incubated for 4 h in
DMEM at pH 7.2 or pH 4.0, and the number of germinated
conidia was determined.
Time-lapse microscopy
For live cell imaging, phagocytosis was carried out as described
above. Briefly, 5610
4 macrophages were plated on polylysine coated
coverslip bottom MatTek plates and allowed to adhere overnight.
The media was then removed and replaced with fresh media
containing S. apiospermum conidia (S. apiospermum to macrophage ratio
of 5:1). This assay was also performed with conidia opsonized with
mAbs F10, C7, C11 and irrelevant mAb (100 mg/mL). Macrophages
and conidia were incubated together for 1 h to allow for completion
of phagocytosis, washed once with fresh media, replenished with
2 mL feeding media and followed by time-lapse imaging every
10 min. Images were collected at 106 using the Axiovert 200 M
inverted microscope and photographed with an AxiocamMR camera
controlledbytheAxioVision4.4software(CarlZeissMicroImaging,
NY). This microscope was housed in a Plexiglas box and the
temperature was stabilized at 37uC with a forced air heater system.
The plate lid was kept in place to prevent evaporation, and 5% CO2
was delivered to a chamber locally at the culture dish. Movie
animations were created using ImageJ software [20].
Germination assay
The germination assay was performed as described with minor
modifications [21]. S. apiospermum conidia (1610
5/mL) were
incubated in DMEM in 24-wells plates at 37uC with 100 mg/mL
o fm A bt oP R M ,c o n t ro lmA bo rP B S .A t2 ,3 ,4 ,8a n d2 4ht h ew e ll s
were analyzed and germinated conidia were counted by microscopy.
At least 100 conidia per field were counted, and the mean value of
three independent counts was calculated. Percent germination was
calculated as germinated conidia/total counted conidia 6100.
Measurement of nitric oxide and superoxide release by
macrophages
J774.16 cells were plated at 10
5 cells per well in 96-well
polystyrene tissue-culture plates. Conidia were pre-incubated with
mAb to PRM, nonspecific IgG, or PBS for 1 h at 37uC prior to
addition to the macrophage monolayer. After 1 h of incubation,
aliquots from the supernatant were collected at different intervals.
Nitric oxide levels were measured using a commercial Griess
reagent kit (Promega). Similarly, superoxide dismutase activity was
determined using a method that involves generation of superoxide
and reduction of the tetrazolium dye MTT to its formazan, which
is measured at 570 nm [22].
Survival studies
For survival studies, groups of 6 BALB/c mice (National Cancer
Institute (NCI), Frederick, MD) were injected intraperitoneally
with either 250 mg of a mAb to PRM, an isotype-matched control
Figure 3. MAbs modify the intracellular fate of S. apiospermum.
Effect of purified PRM and blockage of the CD11 and CD18 receptors
decreased phagocytosis of S. apiospermum conidia (A) and mAbs to PRM
(B) on S. apiospermum phagocytosis by J774.16 cells. Effect of mAbs to
PRM on S. apiospermum killing by J774.16 cells (C). In all the panels, the
values are the averages of three independent experiments, and the error
bars indicatestandarddeviations.Each experimentwasdoneintriplicate.
* P,0.05 for comparison between samples and controls.
doi:10.1371/journal.pntd.0000853.g003
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www.plosntds.org 6 October 2010 | Volume 4 | Issue 10 | e853Figure 4. Phagolysosomal fusion with S. apiospermum. Localization of S. apiospermum conidia in phagolysosomes. MAb F10 increased the
phagolysosomal fusion in J774.16 cells (A). Immunofluorescence analysis of phagolysosomal fusion in J774.16 macrophages by FITC-dextran
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mouse. Two h later, the mice were intratracheally infected with
2.5610
7 S. apiospermum conidia. A similar model was tested using
intravenous inoculation with 1.25610
6 S. apiospermum conidia.
Mice were monitored closely and their survival determined.
For survival studies using a model of invasive candidiasis, 6- to
8-week-old A/J (NCI) mice were inoculated intraperitoneally with
250 mg of mAb F10, an IgG isotype-matched control, or PBS 2 h
prior to intravenous injection of 1610
6 C. albicans yeast cells.
Animals were euthanized at day 7 after infection and the kidneys
were removed, weighed, homogenized and plated onto YPD agar
at 30uC for CFU determinations.
Heterologous yeasts (Candida albicans) phagocytosis
with mAb to S. apiospermum PRM
Phagocytosis assays were performed as above, and C. albicans
yeasts were added to macrophage monolayers (5:1 yeasts:ma-
crophage). Additionally, a second phagocytosis experiment was
performed with J774.16 cells that were incubated with native
PRM (100 mg/mL) 1 h before the addition of yeast cells.
Statistical analysis
Statistical analyses were performed using GraphPad Prism version
5.00 for Windows (GraphPad Software, San Diego CA). Unless
otherwise noted, a one-way analysis of variance using a Kruskall-
Wallis nonparametrical test was used to compare the differences
between groups, and individual comparisons of groups were done
using aBonferoni posttest.A ttestwas used to compare the number of
CFU for different groups. A 90–95% confidence interval was
determined in all experiments. Survival results were analyzed by a
Kaplan-Meyer test to determine the differences between groups.
Results
Binding of mAbs to S. apiospermum PRM
Three IgG1 mAbs, C7, C11, and F10, were generated from a
mouse immunized with PRM. Immunofluorescence microscopy
revealed that the three mAbs against PRM could bind resting
conidia, swollen conidia and hyphae, but only mAb F10 bound
germinating conidia, labeling the cell body and the apical portion of
germinative tube (Figure 1A and B). Fluorescence images of mAbs
C7 (Figure 1C and D) and C11 (Figure 1E and F) show labeling of
swollen conidia. An indirect ELISA was used to quantitatively
evaluate mAb bindingto PRM. There werevariations in bindingby
the different mAbs and the relative order of reactivity was
C7$C11.F10 (Figure 1G). These mAbs can recognize native
PRM (Figure 1G) and fixed swollen conidia by ELISA (Figure 1H),
suggesting that the mAbs recognize epitopes exposed on the native
structure of PRM on the conidia cell surface.
Competition ELISA assays showed that the three mAbs to PRM
bind extremely close or overlapping epitopes (Figure 2A). Indirect
ELISAs using native PRM treated with PNGase F or proteinase K
in 1% SDS solution were used in order to analyze which portion of
the glycoprotein is recognized by the mAbs. Removal of the
carbohydrate from PRM significantly reduced the binding of mAb
F10 to PRM (p,0.05) (Figure 2B). In contrast, no significant
difference was observed when the protein portion was removed,
showing that the epitopes do not contain protein moieties. Similar
results were observed for mAbs C7 and C11 (data not shown).
Binding of mAbs to PRM with other fungi
Indirect ELISAs were performed using different fungal cells to
evaluate the specificity of the mAbs. Interestingly, the mAbs to
PRM recognized conidial forms of S. apiospermum clade 5 (Figure
S1A) and S. prolificans (Figure S1B) as well as yeast forms of H.
capsulatum (Figure S1C), C. albicans (Figure S1D) and C. parapsilosis
(Figure S1E). Hence, there appears to be conserved mannose-
containing structures on the cell surfaces of these fungi.
MAbs to S. apiospermum PRM alter effector functions of
macrophages in vitro
S. apiospermum conidia are effectively phagocytosed by J774.16
macrophages. The addition of soluble PRM significantly reduced
phagocytosis by 25% (Figure 3A). To investigate the involvement
of cellular receptors on conidia uptake, specific blockers were used.
A significant reduction in the phagocytosis of S. apiospermum
conidia was observed using either anti-CD11b or anti-CD18
antibodies, indicating a requirement for CR3 in the interaction
between conidia and macrophages (Figure 3A). Furthermore,
mAbs F10, C7, and C11 significantly decreased the phagocytosis
of conidia compared to conidia incubated with PBS or an isotype-
matched IgG control mAb by 31, 33 and 19%, respectively
(P,0.05) (Figure 3B), suggesting blocking of phagocytosis by these
mAbs. Although phagocytosis was reduced by the mAbs, there
were significant increases of 30–40% in the intracellular survival of
phagocytosed S. apiospermum when compared with PBS or an
isotype-matched control mAb (Figure 3C).
Phagosomal maturation and lysosomal fusion
Fusion of lysosomes with phagosomes was observed by the
detection of FITC-dextran with S. apiospermum conidia within
macrophages. The majority of phagosomes containing S. apios-
permum opsonized with mAb F10 demonstrated co-localization of
FITC-dextran with NHSRho-labeled conidia (Figure 4A and B),
which was significantly increased compared to the other conditions
examined, including mAb C7 (Figure 4A and C), mAb C11
(Figure 4A and D) and irrelevant control mAb (Figure 4A and E).
In order to evaluate the capacity of S. apiospermum conidia to
germinate and survive in acidic media, cells were incubated in
DMEM at pH 7.2 or pH 4.0. Interestingly, there was a significant
increase (127%) in the number of germinated conidia at
pH 4.0,compared to pH 7.2 (Figure 4F).
Interaction between S. apiospermum conidia and J774.16
cells
In order to evaluate if macrophages were able to eliminate the
fungus, S. apiospermum conidia was co-cultured with J774.16 cells.
We observed that the macrophages could not eradicate the S.
apiospermum (Video S1). Further, S. apiospermum conidia could
germinate inside and destroy the macrophages (Video S1). The
same assay was performed with conidia opsonized with mAbs F10,
C7 and C11, and similar results were achieved (data not show).
Metabolic activity and germination of S. apiospermum
conidia in the presence of mAbs to PRM
The metabolic activity in S. apiospermum conidia in the presence
of the three mAbs against PRM was examined by MTT reduction
assay at 1, 2, 3, 4, 5, 6 and 20 h (Figure 5A). The greatest increase
colocalization with NHS-Rho-labeled S. apiospermum conidia. S. apiospermum conidia (red) previously incubated with mAb F10 (B), C7 (C), C11 (D) and
irrelevant control mAb (E) with a J774.16 cell with FITC-dextran (green). Growth of S. apiospermum conidia in neutral and acidic medium (DMEM) for
four h (F) (* P,0.05). Both experiments were performed three times. Scale bar: 50 mm.
doi:10.1371/journal.pntd.0000853.g004
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for F10, C7 and C11, respectively, in comparison with controls.
There were no differences at 20 h (p.0.05), which is consistent
with the germination of all viable conidia in medium alone by this
time.
The influence of mAbs F10, C7 and C11 mAbs on conidia
germination in vitro was examined. The evaluation was based on
visible germinative tube formation. After 4 h of incubation, 77–
80% germination was observed in the presence of each of the
mAbs to PRM, compared to 59% germination for controls
(Figure 5B and 5C–F).
Nitric oxide and superoxide release by J774.16
macrophages-like cells
Addition of mAbs F10, C7 and C11 altered superoxide
production by macrophages. A decrease in superoxide production
occurred in the presence of the mAbs in comparison with the
controls (p,0.05) (Figure 6A). In contrast, the release of nitric
oxide by J774.16 cells co-cultured with S. apiospermum conidia was
not affected by opsonization (Figure 6B).
Survival studies using mAbs to PRM
To determine the effect of the mAbs to PRM in scedosporiosis,
mice were treated with mAb to PRM, irrelevant antibody or PBS
and then intravenously or intratracheally infected with S.
apiospermum conidia. In the intravenous model, administration of
250 mg of mAbs F10 or C7 accelerated disease, resulting in 100%
mortality by day 12 (p,0.05) (Figure 7A). Although 250 mgo f
mAbs C11 also enhanced mortality, the difference from controls
was not statistically significant. To assess for the possibility of a
prozone effect with the dose selected, mice also were treated with
100 or 500 mg of the mAb F10. Administration of 500 mg of mAb
F10 resulted in 100% mortality, but 100 mg was not significantly
different from controls (Figure 7B).
Intratracheal infection resulted in 100% mortality for each
condition examined. MAbs F10 and C7 were able to enhance
mortality, but the difference from controls was only significant for
mAb F10 (p,0.05) (Figure 7C).
Effects of mAbs to PRM on C. albicans. C. albicans growth
was assessed by cultivation of yeasts in YPD broth at 30uC with
and without mAbs to PRM. The growth of C. albicans increased
significantly at 12, 24 and 36 h, respectively, in the presence of
mAb F10 compared to controls (p,0.05) (Figure S2A). However,
mAbs C7 and C11 had no effect on growth. Additionally,
opsonization with the mAbs reduced the phagocytic index by
15%, 40%, and 50% for F10, C7 and C11, respectively, compared
to controls (Figure S2B). To further study mAb effect, we
examined kidney fungal burdens at 7 days after infection using
mAb F10 compared to controls as a measure of dissemination in
intravenously infected mice. Kidney CFUs were twice as great in
mice pre-treated with mAb F10 compared to mice receiving
irrelevant antibody or PBS (p,0.05) (Figure S2C).
Discussion
New medical technologies and therapies have dramatically
amplified the numbers of severely immunosuppressed patients,
increasing the risk for disease from several opportunistic yeasts and
filamentous fungi [23]. In this context, S. apiospermum is emerging
as an important human pathogen [23]. The increase in
scedosporiasis is especially clinically concerning as numerous in
vitro studies have shown that antifungal drugs, such as amphoter-
icin B, nystatin, liposomal nystatin, itraconazole, flucytosine,
fluconazole, terbinafine and ketoconazole, have low in vitro activity
against fungi of the Scedosporium-Pseudallescheria complex [5,24–25].
The implementation of antibody-based therapeutics remains
largely empirical in part because the factors involved in efficacy
are often poorly understood and activation of inflammatory
pathways by antibodies may be detrimental [26–29]. Although we
set out to identify mAbs that would protect against S. apiospermum
disease, our panel of mAb to S. apiospermum PRM modified the
biology of the fungus to enhance virulence.
The mAbs to PRM bound antigen located on the surface of S.
apiospermum strain HLPB mycelia and/or conidia. The mAbs also
reacted with PRM-like compounds on the cell surface of C.
albicans, C. parapsilosis, H. capsulatum, S. apiospermum clade 5 and S.
prolificans. S. apiospermum clade 5 and S. prolificans both display
surface PRM with only minor differences from S. apiospermum
PRM structures [30]. Structural studies on S. apiospermum PRM
have shown that a (1R2)-linked mannosyl units are also located in
side chains that have a-mannosyl or a-rhamnosyl terminal non-
reducing units [31], probably located in the N-linked glycan
component of the PRM [32]. In the present study, we
demonstrated that the carbohydrate portion of the PRM molecule
is essential for recognition of the IgG1 mAbs F10, C7 and C11,
since PNGase F-treatment of PRM (lacking N-glycans) significant-
ly reduced mAb binding. The cross-reactivity with the yeasts is
presumably related with the presence of a-1,2-mannosyl residues
on the surface of these fungi. By competition ELISA, the mAbs
against PRM competed for PRM binding, but they had distinct
labeling patters by immunofluorescence. These results suggested
that mAbs F10, C7 and C11 recognized very close or overlapping
epitopes.
Changes in the cell surface characteristics of resting conidia
during swelling and germination may interfere with mAb
recognition. In S. apiospermum, glucosylceramides are detectable
on the surface of mycelia and pseudohyphae but not conidial
forms, suggesting a differential expression of these glycoconjugates
according to the morphological phase of the fungus [33].
Antibodies against glucosylceramides can modify the transition
conidia-mycelium in S. apiospermum and the cellular differentiation
in C. albicans [33]. Fonsecaea pedrosoi differentially expresses
sialylglycoconjugates and sialidase in distinct morphological stages,
producing these molecules in conidial and mycelial forms, but not
in sclerotic cells, suggesting that the sialic acid expression in F.
pedrosoi varies according to the morphological condition [34].
Many virulent strains of H. capsulatum possess a-(1,3)-glucan in the
yeast cell wall, although it is absent in the mycelial form [35]. This
polysaccharide is likewise present in the yeast phase of two other
pathogenic dimorphic fungi, including Paracoccidiodes brasiliensis
[36] and Blastomyces dermatitidis [37]. In each of these species,
spontaneous variants that have lost their a-(1,3)-glucan have also
lost virulence. So, the presence and the native structure of PRM
could be different according with the stage of S. apiospermum
Figure 5. Effect of mAbs to PRM on the growth of S. apiospermum conidia. Viability of S. apiospermum in the presence of mAbs against PRM
was accessed by MTT assay (A). Effect of mAbs against PRM on S. apiospermum morphogenesis (B–F). Percentage of cells producing germ tubes after
4 h (B). Morphology of S. apiospermum cells assessed by light microscopy after incubation with an irrelevant antibody (C) and with mAbs F10 (D), C7
(E), C11 (F). There is a stimulus in the germination, when mAbs are present (B–F). Bars in the panels represent standard errors and * P,0.05. Scale bar:
100mm. All the experiments were performed three times.
doi:10.1371/journal.pntd.0000853.g005
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binding.
Antibodies can facilitate clearance of fungi from the lungs,
bloodstream, or other tissues through a combination of opsoniza-
tion via the Fc fragment of the antibody and opsonization via
classical pathway deposition of C3 [38]. In the present work we
decided to investigate the involvement of the mAbs and of the
PRM molecule in the phagocytosis of S. apiospermum conidia by
J774.19 macrophage-like cells. Our results demonstrated the
mAbs against PRM reduce the uptake of S. apiospermum conidia
and C. albicans yeasts by J774.16 cells and opsonized conidia have
increased intracellular survival. Previous work from our group
using HEp2 cells showed that when the conidial cells of S.
apiospermum were pre-incubated with polyclonal antibodies to
PRM, the adherence and endocytosis processes were both
inhibited in a dose-dependent manner [10]. These results
suggested an active participation of the fungus in the interaction
process, since HEp2 cells are considered nonprofessional phago-
cytic cells. In professional phagocytic cells like macrophages, Fc
receptors are constitutively active for phagocytosis [39]. Conse-
quently, it is expected that opsonization of yeasts by mAbs
facilitates the ingestion of conidia by macrophages. For example,
H. capsulatum Hsp60-specific mAbs augment yeast cell phagocytosis
by J774.16 macrophage-like cells [17]. However, protective mAbs
against the glucuronoxylomannan (GXM) component of the
Cryptococcus neoformans capsular polysaccharide are not always
effective mediators of cryptococcal phagocytosis [40]. The
mechanism for differential levels of phagocytosis following
opsonization by intact IgG is not known. It is possible that,
depending on epitope specificities, alterations of the antigen
structure may occur on binding that interfere with the interaction
between the bound IgG and macrophage Fc receptors.
Our in vitro experiments were done in the absence of sera, which
does not allow us to directly address the role of complement in the
opsonization via classical pathway deposition of C3. However, the
mAbs used in this study were all IgG1 subclass, which does not
activate complement well [41]. Other subclasses, especially IgG2a
and IgG2b, could contribute to complement-dependent-opsono-
pahgocytosis of conidia in a milieu with serum. The ability of
complement activation by antibodies may be related to their
protective effect in infections, as documented in response to
encapsulated bacteria [42–44]. Interestingly, only 1 of a pair of
IgM mAbs to cryptococcal polysaccharide that activated comple-
ment in vitro were protective in murine models of cryptococcosis
[45]. Furthermore, additional mAbs to cryptococcal polysaccha-
ride suppress rather than enhance binding of C3 to the
cryptococcal capsule and this suppressive activity is dependent
on the antibody isotype and epitope specificity [46]. In addition to
isotype, the epitope specificity influences the biological activity of
antibodies [47]. Hence, the lack of protection in our model by the
IgG1 mAbs to PRM may be due their weak ability to activate
classical pathway deposition of C3, but it may be also be associated
with blocking C3 binding.
Although the F10 mAb increased intracellular survival, it also
enhanced phagolysosomal fusion, which is often associated with
increased killing of microbes within these structures [48]. S.
apiospermum conidia, in the presence or absence of mAbs anti-
PRM, were able to destroy macrophages. Interestingly, we found
that S. apiospermum conidia could readily survive acidic conditions
with enhancement of growth. A possible explanation for the
observed growth benefit is that S. apiospermum proteolytic enzymes
(metallopeptidases or metal dependent peptidases) require an
acidic pH for optimal activity and these peptidases are key
enzymes implicated in microbial metabolism and virulence [1,49–
51]. Surprisingly, mAbs C7 and C11 did not significantly enhance
phagosomal fusion with lysosomes, which could be related with
their different binding properties.
The effect of a mAb depends on several factors, including the
targeted antigen, its function, the cell surface density and
characteristics of the mAb, including specificity, avidity, and
isotype. When a fungal spore germinates, it produces a hypha,
which in turn grows by increasing in length through the
accumulation of newly formed substances on the hyphal wall
[52]. Prevention of some fungal infections presumably requires
control of either spore germination and/or hyphal growth. We
found that mAbs F10, C7 and C11 enhanced conidial germination
compared to controls, indicating that these mAbs may have
accelerated the modification of the inner wall structure. The
increased metabolic activity shown by MTT analysis of S.
apiospermum conidia and C. albicans yeasts exposed to the mAbs is
consistent with the enhancement of cellular processes required for
morphogenesis.
Reactive oxygen and nitrogen species can impact fungal growth.
Activated bronchoalveolar macrophages and neutrophils can kill
H. capsulatum by mechanisms dependent on hydrogen peroxide
and products of the nitric oxide synthase pathway, whereas
fungistasis depends largely on products of the nitric oxide synthase
pathway [53]. In cryptococcosis, superoxide dismutase is impor-
tant because this enzyme can interfere with C. neoformans virulence
by affecting the fungus growth inside the macrophages [54]. In this
context, we decide to evaluate the profile of superoxide and nitric
oxide in S. apiospermum infection in macrophages cells, when the
conidia were opsonized by mAbs F10, C7 and C11. We found that
macrophage superoxide production decreased in the presence of
conidia treated with mAbs compared with controls. Although
nitric oxide is another important part of the oxidative attack
directed against many microbes, the production of nitric oxide was
not affected by the mAbs to PRM, in comparison with controls
[55–56].
MAbs have previously been described to enhance experimental
systemic fungal disease, such as mAb 7B6 for H. capsulatum [17]
and mAb 13F1 for C. neoformans [45,57]. We observed that mAbs
F10 and C7, but not C11, could enhance the disease in murine
models of intravenous and intratracheal infection. Similarly, mice
pre-treated with mAb F10 and infected with C. albicans yeasts had
higher fungal burdens in the kidneys at 7 days after infection
compared to control mice. Additionally, the mAbs to PRM could
enhance C. albicans growth and decrease the phagocytosis of C.
albicans yeasts by J774.16 macrophages relative to controls.
In the present study, we demonstrated that mAbs to PRM are
either non-protective or disease-enhancing in our S. apiospermum
infection models. Hence, administration of mAbs that bind PRM
on the surface of S. apiospermum conidia decreases phagocytosis,
increases intracellular survival, and increases germination that
results in a survival advantage for the fungus during host-pathogen
interactions. We additionally found that the mAbs interacted with
diverse fungal species and modified the virulence of C. albicans.
Hence, antibodies to glycocongugates may significantly impact the
Figure 6. Impact of mAbs to PRM on the release of reactive oxygen species. Opsonization of S. apiospermum conidia with mAbs to PRM
suppressed the release of superoxide by J774.16 cells (* P,0.05) (A). The production of nitric oxide by J774.16 cells was not affected by the presence
or absence of mAb (B). The experiments were performed three times.
doi:10.1371/journal.pntd.0000853.g006
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more detailed understanding of the antagonist behavior of the
mAbs to PRM in S. apiospermum disease and explore the impact of
antibody responses to these important cellular structures.
Supporting Information
Figure S1 Representative curves showing mAbs binding with
different fungi. S. apiospermum clade 5 (A) and S. prolificans (B)
conidia, and H. capsulatum (C), C. albicans (D), and C. parapsilosis (E)
yeasts. The ELISA assays were done in triplicate, three times.
Found at: doi:10.1371/journal.pntd.0000853.s001 (0.81 MB TIF)
Figure S2 MAbs can affect C. albicans growth, phagocytosis and
murine infection. Growth of C. albicans increases in the presence of
mAb F10 compared to controls but not in the presence of mAbs
C7 and C11 (A). Phagocytosis of C. albicans was reduced in the
presence of yeasts opsonized with mAbs to PRM (B). The
experiments were performed three times (* P,0.05). Numbers of
CFU in kidneys at 7 days after sublethal intranasal challenge with
1610
6 C. albicans yeast cells for mice treated intraperitoneally with
mAb F10, irrelevant mAb, or PBS (C). *P,0.05.
Found at: doi:10.1371/journal.pntd.0000853.s002 (0.62 MB TIF)
Video S1 S. apiospermum conidia are able to destroy J774.16
during the infection. In the movie, it is possible to observe that S.
apiospermum conidia can destroy macrophages during the course of
infection. Images were collected at 106.
Found at: doi:10.1371/journal.pntd.0000853.s003 (2.54 MB AVI)
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